Lack of Cytoplasmic ERK Activation Is an Independent Adverse Prognostic Factor in Primary Cutaneous Melanoma
- 1 November 2008
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 128 (11) , 2696-2704
- https://doi.org/10.1038/jid.2008.134
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- ERK2 but not ERK1 plays a key role in hepatocyte replicationHepatology, 2007
- Lack of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Signaling Shows a New Type of MelanomaCancer Research, 2007
- ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentiallyJournal of Biology, 2006
- BRAF somatic mutations in malignant melanoma and melanocytic naeviMelanoma Research, 2006
- Examination of Mutations in BRAF, NRAS, and PTEN in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2006
- Expression of Activated Akt and PTEN in Malignant MelanomasAmerican Journal of Clinical Pathology, 2005
- Expression of Activated Akt and PTEN in Malignant Melanomas : Relationship With Clinical OutcomeAmerican Journal of Clinical Pathology, 2005
- Apoptosis shifts to necrosis via intermediate types of cell death by a mechanism depending on c- myc and bcl-2 expressionCell and tissue research, 2004
- Incidence of BRAF Oncogene Mutation and Clinical Relevance for Primary Cutaneous MelanomasClinical Cancer Research, 2004
- Mutations of the BRAF gene in human cancerNature, 2002